A study of the anticholinesterase and anticurare effects of some cholinesterase inhibitors.
D000963:Antimetabolites / Q000494:pharmacology*; D002784:Cholesterol; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003472:Curare / Q000494:pharmacology*; D004491:Edrophonium / Q000494:pharmacology; D006221:Halothane / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009388:Neostigmine / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D011729:Pyridostigmine Bromide / Q000494:pharmacology*; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D000963:Antimetabolites; D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D004491:Edrophonium; D003472:Curare; D002784:Cholesterol; D013390:Succinylcholine; D011729:Pyridostigmine Bromide; D006221:Halothane; D014403:Tubocurarine